Sat, Aug 23, 2014, 4:22 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

oneleftistoomany 11 posts  |  Last Activity: Aug 19, 2014 8:06 AM Member since: Dec 4, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    What did you learn from your QCOR ride?

    by pensiveman2000 Aug 16, 2014 3:54 PM
    oneleftistoomany oneleftistoomany Aug 19, 2014 8:06 AM Flag

    1. Number one on your list is also number one on my list, and it boils down to "patience".
    Gotta admit--a couple of those solid QCOR earnings reports, followed by a 5-6% decline in share price over the next few sessions? Had me pacing around, talking to myself.
    2. The importance of trading around a core, my practice for many years--but even more important, and potentially profitable, with stocks under short attack.
    3. The skill, planning, creativity, and resources of short sellers.
    Think what you will about Raggedy Andy Left and his minions, but they left their mark on QCOR and on all of us--and with precious few actual facts on their side. They do their homework, communicate effectively, lay out a strategy, and of course, move without conscience. And, they create opportunity for patient investors.
    4. The integrity of the CEO--if you suspect the integrity of management at any point, put your tail between your legs and run. A good product is not enough.
    My investment mistakes this year (e.g. UNXL, GALE) resulted from CEOs that provided plenty of evidence they were slippery promoters. I just chose to ignore the evidence, including my own gut feel. With QCOR, I never once thought Bailey, Cartt were anything but stand up guys.

    A heartfelt congratulations to longs who stayed the course. You got what you deserved. And a personal thanks--if not for this forum, I would have been less aggressive.

    Lastly, a shout out to Don Bailey. That dry, feisty old engineer moved the chains consistently, kept faith with investors, got QCOR into the end zone, and took us along.

    Go MNK--liking Mark Trudeau lots--$110 by this time next year--that's my prediction.

  • Reply to

    OT: AMBS UP 8% just this morning

    by caffeinsomniac Jul 14, 2014 10:38 AM
    oneleftistoomany oneleftistoomany Jul 14, 2014 10:42 AM Flag

    Go QCOR. Congrats to all longs. Triple digits coming I think.
    Go AMBS.

    Sentiment: Buy

  • Reply to


    by ymbacc Jun 26, 2014 12:45 AM
    oneleftistoomany oneleftistoomany Jul 2, 2014 8:32 AM Flag

    IDRA big position for me as well.

  • Reply to

    I honestly cant believe you all fell for it

    by mkerryfuller Jun 25, 2014 10:06 PM
    oneleftistoomany oneleftistoomany Jun 26, 2014 7:40 AM Flag

    bump--comment never registered.

    Sentiment: Buy

  • Reply to

    I honestly cant believe you all fell for it

    by mkerryfuller Jun 25, 2014 10:06 PM
    oneleftistoomany oneleftistoomany Jun 26, 2014 7:25 AM Flag

    Admitting this here in a public forum...I can't stop reading The Raven.
    Like watching a punch drunk fighter come out for another round.
    Or a Green Party candidate run for office.
    Or Andy Left tangle with his ex-wife.
    You cringe, you squint, you know what's coming, but you can't tear your eyes away.

    LOL. He even admits he got crushed by the QCOR merger, and still he's back for more. He is the Rodney Dangerfield of financial writers (My therapist told me I was crazy. I said I wanted a second opinion. He said, "Ok, you're ugly too.").

    By the way, QCOR is not the only company where he confuses fact and fiction. I'm currently accumulating NQ--and Birdie is right in there as well--just as outrageous--shilling for the shorts.

    On my only serious note--have been dealing with the FDA for some 30 years. They get hundreds of inquiries annually from credentialed medical professionals--and claim to "review" them all. Maybe they do, maybe they don't--I really don't know.

    But I can say this with some authority--most get answered with a form letter or go unanswered. My opinion? Raven would stand a better chance of response writing love letters to Scarlet Johansson.

    Sentiment: Buy

  • oneleftistoomany oneleftistoomany Jun 10, 2014 5:37 PM Flag

    If looking for another short target, I've been accumulating NQ, which has been annihilated by the notorious MuddyWaters (Carson Block), who spread fabrications about the company as bold as any of the FUD we've heard at QCOR over the past several years from RaggedyAndy Left and QTR.

    QCOR at $88? No brainer as so many posters have concluded.

    Sentiment: Buy

  • oneleftistoomany oneleftistoomany Jun 6, 2014 9:24 AM Flag

    Figured as much.
    I noticed you've been giving that clown-shill Herb Greenberg a little extra "exposure".
    How thoughtful of you to put his writings up in brighter lights and to new audiences.

  • oneleftistoomany oneleftistoomany Jun 6, 2014 8:58 AM Flag

    Hilarious. Another notch in your belt. Maybe introduce Herb to Shrek?

  • oneleftistoomany oneleftistoomany Jun 6, 2014 8:58 AM Flag

    Thanks. Been keeping up with posts here, busy aggravating shorts on other fronts.
    Hey--everybody should have a hobby--that's what I've heard anyway.

  • oneleftistoomany oneleftistoomany Jun 6, 2014 8:27 AM Flag

    Great point Mike. Its a tiny victory for Acthar the way I see it, allowing doctors more freedom of movement to prescribe Acthar Gel for appropriate patients.

    Sentiment: Buy

  • Differences in Cigna coverage are insignificant in my opinion. Agree with mikey and other posters.
    Same old, same old. Every Acthar script will be scrutinized carefully.

    In the 6.14 bulletin, Cigna called out that Acthar was expensive and they deleted the specific language listing conditions for coverage of MS exacerbations and other indications (failure with corticosteroids).

    Now here's what's a bit interesting:
    In the 6.14 bulletin, Cigna has removed the language "when there is failure of corticosteroid therapy" as a condition for prescribing Acthar Gel. This could go a good place for Acthar. I read it to mean prescribers can make their own decision when to prescribe Acthar Gel. For example: if a patient has a known bad history with corticosteroids, or the doc feels for any reason that Acthar offers a better outcome (e.g., violent and uncontrolled MS spasms or debilitating PM/DM)--they can skip corticosteroids and go straight to Acthar Gel.

    Cigna will apply the usual tactics to discourage Acthar Gel scripts, and then they will cover when medically necessary.

    Comment welcome.
    I'll be adding on dips.

    Sentiment: Buy

93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.